Community-Acquired Pneumonia Due to Pandemic A(H1N1)2009 Influenzavirus and Methicillin Resistant Staphylococcus aureus Co-Infection

Background Bacterial pneumonia is a well described complication of influenza. In recent years, community-onset methicillin-resistant Staphylococcus aureus (cMRSA) infection has emerged as a contributor to morbidity and mortality in patients with influenza. Since the emergence and rapid dissemination of pandemic A(H1N1)2009 influenzavirus in April 2009, initial descriptions of the clinical features of patients hospitalized with pneumonia have contained few details of patients with bacterial co-infection. Methodology/Principal Findings Patients with community–acquired pneumonia (CAP) caused by co-infection with pandemic A(H1N1)2009 influenzavirus and cMRSA were prospectively identified at two tertiary hospitals in one Australian city during July to September 2009, the period of intense influenza activity in our region. Detailed characterization of the cMRSA isolates was performed. 252 patients with pandemic A(H1N1)2009 influenzavirus infection were admitted at the two sites during the period of study. Three cases of CAP due to pandemic A(H1N1)2009/cMRSA co-infection were identified. The clinical features of these patients were typical of those with S. aureus co-infection or sequential infection following influenza. The 3 patients received appropriate empiric therapy for influenza, but inappropriate empiric therapy for cMRSA infection; all 3 survived. In addition, 2 fatal cases of CAP caused by pandemic A(H1N1)2009/cMRSA co-infection were identified on post–mortem examination. The cMRSA infections were caused by three different cMRSA clones, only one of which contained genes for Panton-Valentine Leukocidin (PVL). Conclusions/Significance Clinicians managing patients with pandemic A(H1N1)2009 influenzavirus infection should be alert to the possibility of co-infection or sequential infection with virulent, antimicrobial-resistant bacterial pathogens such as cMRSA. PVL toxin is not necessary for the development of cMRSA pneumonia in the setting of pandemic A( H1N1) 2009 influenzavirus co-infection.

[1]  W. Anderson,et al.  2007 National Statement on Ethical Conduct in Human Research , 2011, Internal medicine journal.

[2]  Rogan Lee,et al.  Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case–control study , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  Lyn Finelli,et al.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. , 2009, The New England journal of medicine.

[4]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[5]  R. Bellomo,et al.  Critical care services and 2009 H1N1 influenza in Australia and New Zealand. , 2009, The New England journal of medicine.

[6]  Kwok-Hung Chan,et al.  Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus. , 2009, The Journal of infection.

[7]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. , 2009, The Journal of antimicrobial chemotherapy.

[8]  C. Reed,et al.  Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children , 2009, The Pediatric infectious disease journal.

[9]  Philip M Polgreen,et al.  Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. , 2009, Annals of emergency medicine.

[10]  Anthony S Fauci,et al.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. , 2008, The Journal of infectious diseases.

[11]  G. Dennis Shanks,et al.  Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic , 2008, Emerging infectious diseases.

[12]  S. Monecke,et al.  Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. , 2008, FEMS immunology and medical microbiology.

[13]  S. Monecke,et al.  DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  G. Nimmo,et al.  Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. , 2008, International journal of antimicrobial agents.

[15]  W. Witte,et al.  Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. , 2007, The Journal of antimicrobial chemotherapy.

[16]  Yhu-Chering Huang,et al.  Prevalence of Methicillin-Resistant Staphylococcus aureus Nasal Colonization among Taiwanese Children in 2005 and 2006 , 2007, Journal of Clinical Microbiology.

[17]  F. O'Brien,et al.  Contour-clamped homogeneous electric field electrophoresis of Staphylococcus aureus , 2006, Nature Protocols.

[18]  E. Walsh,et al.  Pulmonary complications of interpandemic influenza A in hospitalized adults. , 2006, The Journal of infectious diseases.

[19]  C. Bridges,et al.  Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season , 2006, Emerging infectious diseases.

[20]  D. Whiley,et al.  A 5'-nuclease real-time reverse transcriptase-polymerase chain reaction assay for the detection of a broad range of influenza A subtypes, including H5N1. , 2005, Diagnostic microbiology and infectious disease.

[21]  T. Louie,et al.  Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette Chromosome mec Types I to V in Methicillin-Resistant Staphylococcus aureus , 2005, Journal of Clinical Microbiology.

[22]  S. Kaplan,et al.  Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  K. Kleesiek,et al.  Use of Bacteriophage MS2 as an Internal Control in Viral Reverse Transcription-PCR Assays , 2005, Journal of Clinical Microbiology.

[24]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[25]  J. Rothgänger,et al.  Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management , 2003, Journal of Clinical Microbiology.

[26]  S. H. Hinrichs,et al.  Comparative Molecular Analysis of Community- or Hospital-Acquired Methicillin-Resistant Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.

[27]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[28]  P. Vanhems,et al.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients , 2002, The Lancet.

[29]  Nicholas P. J. Day,et al.  Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus , 2000, Journal of Clinical Microbiology.

[30]  J. D. Williams.  1996 Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  L. Miller,et al.  Interpretive criteria for testing susceptibility of staphylococci to mupirocin , 1997, Antimicrobial agents and chemotherapy.

[32]  Roger Cluzel,et al.  Overview of the Comité de l'Antibiogramme de la Société Française de Microbiologie. , 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[34]  J. Moore,et al.  Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. , 1958, Lancet.

[35]  J. Stockman,et al.  Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009 , 2011 .

[36]  J. Stockman.  Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection , 2010 .

[37]  R. Leggiadro.  Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May–August 2009 , 2010 .

[38]  Abstr Act,et al.  Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand , 2009 .

[39]  C. Whitney,et al.  Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[40]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[41]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[42]  I. Kay,et al.  Rapid detection of mecA and nuc genes in staphylococci by real-time multiplex polymerase chain reaction. , 2005, Diagnostic microbiology and infectious disease.

[43]  Mian Cai,et al.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[45]  B. Spratt,et al.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. , 2000, Journal of clinical microbiology.

[46]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[47]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[48]  W. Pruzanski,et al.  [Staphylococcus aureus pneumonia]. , 1960, Harefuah.